US7599161095
US7599161095
Repligen Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 11.04B EUR | 7.7B EUR | 6.64B EUR | 9.23B EUR |
Enterprise Value | 9.13B EUR | 7.78B EUR | 6.75B EUR | 9.35B EUR |
Valuation Multiples | ||||
Trailing P/E | 238.19x | 185.34x | 129.29x | 214.32x |
Forward P/E | 65.78x | -- | -- | -- |
Price to Sales | 14.06x | 9.81x | 8.71x | 16.22x |
Price to Book | 4.65x | 3.65x | 3.16x | 4.38x |
EV/Revenue | 11.63x | 9.91x | 8.84x | 16.44x |
EV/EBITDA | 63.34x | 48.79x | 44x | 82.95x |
Price to FCF (P/FCF) | 97.33x | 69.89x | 63.61x | 113.79x |
EV/FCF | 80.47x | 70.66x | 64.62x | 115.31x |
FCF Yield | 1.03% | 1.43% | 1.57% | 0.88% |